Dr. Singh is especially sensitive to the needs and concerns of women with hair loss. Female Pattern Hair Loss or Androgenetic Alopecia can be particularly devastating. 20- 30% of all women suffer from female pattern hair loss (FPHL) in the US. Society expects to see hair thinning and hairline recession in men; however, it is particularly disconcerting when it occurs in women.
Fortunately, most women can be aided with a combination of both medical and surgical therapies. Minoxidil is the only FDA approved treatment for FPHL at this time. In the majority of women, it stops progression of the disease and can rethicken hair. Many women with FPHL are candidates for hair transplantation. With the use of follicular unit transplantation with smaller 1-4 follicular unit grafts, very good cosmetic, natural-appearing results can be achieved.
Consultation for hair transplantation with a female patient differs somewhat than with a male patient. Because of the nature of FPHL, the patient is often more concerned about the ‘see-through’ nature of the scalp, as opposed to regression of the hairline or loss at the crown of the scalp. In addition, it is important to perform a detailed scalp examination and consider further labs and potentially scalp biopsy to differentiate FPHL from other types of hairloss.
The net cosmetic outcome and density will reflect the amount of hairs transplanted minus the ongoing hair loss. In addition, placing the hairs predominantly in the frontal scalp, as opposed to diffusely spreading it throughout the involved areas will lead to a better cosmetic outcome. The transplanted hairs will be placed in between existing hairs.